Abstract
The in vitro activity of S-25930 and S-25932, two new 4-quinolones, against 450 aerobic gram-negative organisms isolated from cancer patients was evaluated and compared with the activity of ciprofloxacin, enoxacin, difloxacin (A-56619), and A-56620. Both agents inhibited most members of the family Enterobacteriaceae at concentrations of less than or equal to 2.0 micrograms/ml, but their activity against Pseudomonas aeruginosa was inferior to that of other quinolones. Although considerably less active than ciprofloxacin and A-56620, S-25930 was frequently two- to eightfold more active than S-25932 and was comparable to difloxacin and enoxacin against most isolates.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bodey G. P. Antibiotics in patients with neutropenia. Arch Intern Med. 1984 Sep;144(9):1845–1851. [PubMed] [Google Scholar]
- Eliopoulos G. M., Moellering A. E., Reiszner E., Moellering R. C., Jr In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620. Antimicrob Agents Chemother. 1985 Oct;28(4):514–520. doi: 10.1128/aac.28.4.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harris R. L., Fainstein V., Elting L., Hopfer R. L., Bodey G. P. Bacteremia caused by Aeromonas species in hospitalized cancer patients. Rev Infect Dis. 1985 May-Jun;7(3):314–320. doi: 10.1093/clinids/7.3.314. [DOI] [PubMed] [Google Scholar]
- Hoy J. F., Rolston K. V., Ho D. H., Alvarez M., Thirolf P., Bodey G. P. In vitro activity of BRL 36650, a new semisynthetic penicillin. Antimicrob Agents Chemother. 1986 Jun;29(6):972–976. doi: 10.1128/aac.29.6.972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rolston K., Guan Z., Bodey G. P., Elting L. Acinetobacter calcoaceticus septicemia in patients with cancer. South Med J. 1985 Jun;78(6):647–651. doi: 10.1097/00007611-198506000-00007. [DOI] [PubMed] [Google Scholar]